Positive regulatory feedback from EMA and FDA for mouthwash treatment known as Muc1 (previously NG11-2),to help prevent radiotherapy-induced mouth ulcers (oral mucositis)
24th April 2026
VasoDynamics Ltd, the pharmaceutical company developing patient-friendly therapies for the prevention of debilitating side-effects induced by anti-cancer treatments, is pleased t...